Post-Menopausal Osteoporosis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene - Dove Medical Press



Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene 
Dove Medical Press
Background: In clinical practice, patients with postmenopausal osteoporosis have often shown a poor response to treatment with an antiresorptive agent for several years. The purpose of this study was to investigate the efficacy of switching raloxifene ...

 


Post Menopausal Osteoporosis Market Research Report 2017 to 2025 - Research of Market



Post Menopausal Osteoporosis Market Research Report 2017 to 2025 
Research of Market
Post Menopausal Osteoporosis-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across Post Menopausal Osteoporosis. The report provides a complete understanding of the ...

and more » 


Post Menopausal Osteoporosis ? Pipeline Review, H1 - MilTech



Post Menopausal Osteoporosis ? Pipeline Review, H1 
MilTech
Post Menopausal Osteoporosis Market report provides comprehensive information on the therapeutics under development for Post Menopausal Osteoporosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of ...

 


USPSTF recommends osteoporosis screening, testing in women aged 65 and older - Clinical Advisor



Clinical Advisor
 
USPSTF recommends osteoporosis screening, testing in women aged 65 and older 
Clinical Advisor
... evidence that screening with bone mineral testing can detect osteoporosis and that treatment of women with osteoporosis can provide at least a moderate benefit in preventing fractures in women aged 65 years and older as well as postmenopausal women ...

 


Romosozumab and Alendronate Curb Fracture in Osteoporosis - Medscape



Medscape
 
Romosozumab and Alendronate Curb Fracture in Osteoporosis 
Medscape
SAN DIEGO ? For postmenopausal women with osteoporosis, sequential treatment with romosozumab and alendronate is better than alendronate alone, according to results from the phase 3 Active-Controlled Fracture Study in Postmenopausal Women With ...

 


Bone Strength, BMD Assessment Cost-Effective for Postmenopausal Osteoporosis Screening - Rheumatology Advisor



Rheumatology Advisor
 
Bone Strength, BMD Assessment Cost-Effective for Postmenopausal Osteoporosis Screening 
Rheumatology Advisor
HealthDay News ? Combined assessment of bone strength and bone mineral density is a cost-effective strategy for osteoporosis screening in postmenopausal women, according to a study published in Radiology. Christoph A. Agten, MD, from the NYU ...

 


Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis - Pharmacy Today, American Pharmacists Association, pharmacist.com



Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis 
Pharmacy Today, American Pharmacists Association, pharmacist.com
The multinational VERO clinical trial investigated whether teriparatide or risedronate more effectively prevents new fractures in post-menopausal patients with severe osteoporosis. A sample population of 1,360 such women were recruited and evenly ...

 


New health guidance on breast cancer - Medical Xpress



New health guidance on breast cancer 
Medical Xpress
In their draft guidance, the National Institute for Health and Care Excellence (NICE) said that postmenopausal women with a family history of breast cancer should now be offered the drug anastrozole, and not tamoxifen, to help prevent the onset of the ...

 


Osteoporosis Drugs Market to Represent a Value of US $14,786.7 ... - Digital Journal



Osteoporosis Drugs Market to Represent a Value of US $14,786.7 ... 
Digital Journal
Digital Journal is a digital media news network with thousands of Digital Journalists in 200 countries around the world. Join us!

and more » 


USPSTF: Screen All Women 65 and Older for Osteoporosis - AAFP News



AAFP News
 
USPSTF: Screen All Women 65 and Older for Osteoporosis 
AAFP News
The task force also recommended screening for osteoporosis with bone measurement testing in postmenopausal women younger than 65 who are at increased risk for osteoporosis; this was also a "B" recommendation. "Without screening, most women won't ...